Tobey J. MacDonald
Affiliations: | Molecular Medicine | The George Washington University, Washington, DC, United States |
Area:
Oncology, Molecular Biology, Cell BiologyGoogle:
"Tobey MacDonald"Children
Sign in to add trainee| Thamara J. AbouAntoun | grad student | 2008 | The George Washington University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shahab SW, Roggeveen CM, Sun J, et al. (2023) The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. Molecular Oncology |
| Kunhiraman H, McSwain L, Shahab SW, et al. (2023) IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma. Acta Neuropathologica Communications. 11: 62 |
| Yuan L, Zhang H, Liu J, et al. (2021) STAT3 is required for Smo-dependent signaling and mediates Smo-targeted treatment resistance and tumorigenesis in Shh medulloblastoma. Molecular Oncology |
| MacDonald TJ, Liu J, Yu B, et al. (2021) Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo. Cancers. 13 |
| Dobson THW, Tao RH, Swaminathan J, et al. (2019) Transcriptional repressor REST drives lineage stage-specific chromatin compaction at and increases AKT activation in a mouse model of medulloblastoma. Science Signaling. 12 |
| Zhu D, Osuka S, Zhang Z, et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell. 33: 1004-1016.e5 |
| Bhatia S, Baig NA, Timofeeva O, et al. (2015) Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget. 6: 8929-46 |
| McKinney N, Yuan L, Zhang H, et al. (2015) EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. Journal of Neuro-Oncology. 121: 109-18 |
| Petersen W, Liu J, Yuan L, et al. (2014) Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283. Cancer Letters. 354: 68-76 |
| Kieran MW, Yao X, Macy M, et al. (2014) FINAL RESULTS OF A PROSPECTIVE MULTI-INSTITUTIONAL PHASE II STUDY OF EVEROLIMUS (RAD001), AN MTOR INHIBITOR, IN PEDIATRIC PATIENTS WITH RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA. A POETIC CONSORTIUM TRIAL Neuro-Oncology. 16: iii27-iii27 |